Triple therapy or etanercept after methotrexate failure in RA?

被引：0
|
作者：
Ronald F. van Vollenhoven
Katerina Chatzidionysiou
机构：
[1] Unit for Clinical Therapy Research,
[2] Inflammatory Diseases,undefined
[3] The Karolinska Institute,undefined
[4] Karolinska University Hospital,undefined
[5] D1:00,undefined
来源：
Nature Reviews Rheumatology | 2013年 / 9卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Since the 1990s, patients with rheumatoid arthritis have been treated with at least one DMARD. Methotrexate, which is usually the first-line treatment, elicits good or even excellent clinical results in 20–30% of patients—but in most patients it does not. Thus, an important question is what to do after methotrexate failure.
引用
收藏
页码：510 / 512
页数：2
相关论文
共 50 条
12345